Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Should You Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up prior to trading on Friday . The stock had previously closed at $17.41, but opened at $19.13. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $19.26, with a volume of 7,366 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. UBS Group boosted their price objective on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The stock has a 50 day moving average price of $16.67.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.